Cumberland Pharmaceuticals Inc.
CPIX
$6.29
-$0.33-4.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.64M | -6.64M | -2.10M | -2.59M | -2.19M |
| Total Depreciation and Amortization | 4.21M | 4.21M | 3.97M | 4.42M | 4.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 233.10K | 233.10K | 311.20K | -205.40K | -914.40K |
| Change in Net Operating Assets | 2.77M | 2.77M | 1.91M | 4.36M | 4.88M |
| Cash from Operations | 577.20K | 1.42M | 4.93M | 6.83M | 7.12M |
| Capital Expenditure | -23.80K | -23.80K | -71.40K | -73.70K | -65.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.80M | -3.80M | -4.92M | -1.87M | -1.00M |
| Cash from Investing | -3.83M | -3.54M | -4.71M | -1.66M | -779.50K |
| Total Debt Issued | -- | -- | -- | 5.50M | 16.49M |
| Total Debt Repaid | 0.00 | 0.00 | -10.04M | -16.35M | -27.34M |
| Issuance of Common Stock | 0.00 | 0.00 | 5.27M | 5.27M | 5.27M |
| Repurchase of Common Stock | -71.40K | -71.40K | -256.30K | -354.70K | -443.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.76M | -1.76M | -1.57M | -1.35M | -1.41M |
| Cash from Financing | -1.83M | -1.98M | -6.75M | -7.44M | -7.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.08M | -4.10M | -6.52M | -2.27M | -1.25M |